187 related articles for article (PubMed ID: 30045641)
21. Oral candidiasis in patients with kidney transplantation in Iran: prevalence and antifungal susceptibility pattern.
Ghadimi F; Rodrigues CF; Mohammadi SR; Roudbary M; Dos Santos AL; Aslani P; Nikoomanesh F
Future Microbiol; 2023 Jul; 18():715-722. PubMed ID: 37665236
[No Abstract] [Full Text] [Related]
22. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
[TBL] [Abstract][Full Text] [Related]
23. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G
J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465
[TBL] [Abstract][Full Text] [Related]
24. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
Bulacio L; Paz M; Ramadán S; Ramos L; Pairoba C; Sortino M; Escovich L; López C
J Mycol Med; 2012 Dec; 22(4):348-53. PubMed ID: 23518170
[TBL] [Abstract][Full Text] [Related]
25. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
Maninder J; Usha A
J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
[TBL] [Abstract][Full Text] [Related]
26. The in vitro post-antifungal effect of nystatin on Candida species of oral origin.
Ellepola AN; Samaranayake LP
J Oral Pathol Med; 1999 Mar; 28(3):112-6. PubMed ID: 10069538
[TBL] [Abstract][Full Text] [Related]
27. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
Liu XP; Fan SR; Peng YT; Zhang HP
J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
[TBL] [Abstract][Full Text] [Related]
28. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
[TBL] [Abstract][Full Text] [Related]
29. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
30. In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus.
Manfredi M; McCullough MJ; Polonelli L; Conti S; Al-Karaawi ZM; Vescovi P; Porter SR
Oral Microbiol Immunol; 2006 Jun; 21(3):177-82. PubMed ID: 16626375
[TBL] [Abstract][Full Text] [Related]
31. A sensitive and a rapid multiplex polymerase chain reaction for the identification of Candida species in concentrated oral rinse specimens in patients with diabetes.
Sampath A; Weerasekera M; Gunasekara C; Dilhari A; Bulugahapitiya U; Fernando N
Acta Odontol Scand; 2017 Mar; 75(2):113-122. PubMed ID: 27960572
[TBL] [Abstract][Full Text] [Related]
32. Oral candidal speciation, virulence and antifungal susceptibility in type 2 diabetes mellitus.
Patel PN; Sah P; Chandrashekar C; Vidyasagar S; Venkata Rao J; Tiwari M; Radhakrishnan R
Diabetes Res Clin Pract; 2017 Mar; 125():10-19. PubMed ID: 28131069
[TBL] [Abstract][Full Text] [Related]
33. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
34. Extracellular phospholipase production of oral Candida albicans isolates from smokers, diabetics, asthmatics, denture wearers and healthy individuals following brief exposure to polyene, echinocandin and azole antimycotics.
Ellepola AN; Samaranayake LP; Khan ZU
Braz J Microbiol; 2016; 47(4):911-916. PubMed ID: 27522928
[TBL] [Abstract][Full Text] [Related]
35. Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles.
Yan Z; Young AL; Hua H; Xu Y
J Rheumatol; 2011 Nov; 38(11):2428-31. PubMed ID: 21844143
[TBL] [Abstract][Full Text] [Related]
36. [25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans].
Zhang X; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):279-84. PubMed ID: 27116986
[TBL] [Abstract][Full Text] [Related]
37. Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital.
Savastano C; de Oliveira Silva E; Gonçalves LL; Nery JM; Silva NC; Dias AL
Braz J Microbiol; 2016; 47(2):367-72. PubMed ID: 26991302
[TBL] [Abstract][Full Text] [Related]
38. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
39. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
40. Colonization of voice prostheses by albicans and non-albicans Candida species.
Bauters TG; Moerman M; Vermeersch H; Nelis HJ
Laryngoscope; 2002 Apr; 112(4):708-12. PubMed ID: 12152601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
